CIR / CII
Our experts can help you determine whether your clinical, epidemiological and medical device research is eligible for the CIR.
Find out what impact the PLF 2025 will have on the CII, the JEI and JEIC statuses and the CICo?
Discover the key changes described in the CIR 2024 guide vs. the 2023 edition, analyzed by our experts.
Discover the deadline for applying for CIR approval in 2024
Find out how to save time in identifying partners for your innovation projects
Discover the new law to combat organized tax fraud, including fictitious tax credits
Find out about new case law on the CIR eligibility of sub-projects linked to the inseparability of work.
Find out about case law clarifications on the CIR concerning the state of the art, staff eligibility and expert appraisal costs.
Discover new case law on the subject of capitalized R&D expenses declared as depreciation allowances in the CIR.
Find out how Mews Partners has ensured 100% validation of declared expenses and optimized the structuring of R&D projects over the years thanks to G.A.C. Group.
Discover the importance of accurate time tracking for the Research Tax Credit (CIR), confirmed by several rulings, and secure your CIR.
Find out what the Conseil d'Etat has to say about how young doctor status is taken into account in the CIR.
Discover the eligibility criteria for the Young Innovative Growth Company (JEIC) status for SMEs.
Find out how to anticipate risks and secure your practices to make your CIR a sustainable source of financing for your R&D and innovation.
Services
Sectors